Development of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists

Por Hill, Matthew D., Fang, Haiquan, King, H. Dalton, Iwuagwu, Christiana I., McDonald, Ivar M., Cook, James, Zusi, F. Christopher, Mate, Robert A., Knox, Ronald J., Post-Munson, Debra, Easton, Amy, Miller, Regina, Lentz, Kimberley, Clarke, Wendy, Benitex, Yulia, Lodge, Nicholas, Zaczek, Robert, Denton, Rex, Morgan, Daniel, Bristow, Linda, Macor, John E., Olson, Richard
Publicado no ACS Med Chem Lett (2016)

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor

Por Gillman, Kevin W., Starrett, John E., Parker, Michael F., Xie, Kai, Bronson, Joanne J., Marcin, Lawrence R., McElhone, Kate E., Bergstrom, Carl P., Mate, Robert A., Williams, Richard, Meredith, Jere E., Burton, Catherine R., Barten, Donna M., Toyn, Jeremy H., Roberts, Susan B., Lentz, Kimberley A., Houston, John G., Zaczek, Robert, Albright, Charles F., Decicco, Carl P., Macor, John E., Olson, Richard E.
Publicado em 2010

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia

Por King, Dalton, Iwuagwu, Christiana, Cook, Jim, McDonald, Ivar M., Mate, Robert, Zusi, F. Christopher, Hill, Matthew D., Fang, Haiquan, Zhao, Rulin, Wang, Bei, Easton, Amy E., Miller, Regina, Post-Munson, Debra, Knox, Ronald J., Gallagher, Lizbeth, Westphal, Ryan, Molski, Thaddeus, Fan, Jingsong, Clarke, Wendy, Benitex, Yulia, Lentz, Kimberley A., Denton, Rex, Morgan, Daniel, Zaczek, Robert, Lodge, Nicholas J., Bristow, Linda J., Macor, John E., Olson, Richard E.
Publicado no ACS Med Chem Lett (2017)